RxSight (RXST)
(Delayed Data from NSDQ)
$47.41 USD
+0.64 (1.37%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $47.39 -0.02 (-0.04%) 5:16 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Bottom 43% (143 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.13 | 1.57 | 9.99 |
Current Quarter Estimate | -0.11 | 3.93 | 61.00 |
Year Ago Quarter Estimate | -0.40 | 3.85 | 54.84 |
Next Quarter Estimate | -0.06 | 3.92 | 63.00 |
Next Year Estimate | 0.09 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 75.89 | 12.00 | 15.67 |
Next Year | 126.47 | 22.20 | 9.31 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 14.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | 10.61 | 2.42 |
Price/Cash Flow (MRFY) | NA | 17.22 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -44.01% | 7.19% |
Return on Equity (TTM) | -27.68% | -233.34% |
Debt to Equity (MRQ) | NA | 30.84 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.